Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
LIPID DISORDERS / RESEARCH LETTER
Awareness and management of pediatric familial hypercholesterolemia: a Polish physician survey
1
Department of Pediatrics and Pediatric Endocrinology, Faculty of Medical Sciences, Medical University of Silesia, Katowice, Poland
These authors had equal contribution to this work
Submission date: 2025-09-06
Final revision date: 2025-10-13
Acceptance date: 2025-10-27
Online publication date: 2025-10-31
Corresponding author
Kamila Szeliga
Department of Pediatrics and Pediatric Endocrinology Faculty of Medical Sciences Medical University of Silesia 16 Medyków St 40-752 Katowice, Poland
Department of Pediatrics and Pediatric Endocrinology Faculty of Medical Sciences Medical University of Silesia 16 Medyków St 40-752 Katowice, Poland
Arch Med Sci 2025;21(5):2175-2178
TOPICS
REFERENCES (12)
1.
Austin MA. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 2004; 160: 407-20.
2.
Humphries SE, Futema M. Genetic determinants of the familial hypercholesterolaemia phenotype. Ann Human Genet 2025; 89: 293-304.
3.
Groselj U, Wiegman A, Gidding SS. Screening in children for familial hypercholesterolaemia: start now. Eur Heart J 2022; 43: 3209-12.
4.
Wiegman A, Gidding SS, Watts GF, et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J 2015; 36: 2425-37.
5.
Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ 1991; 303: 893-6.
6.
Mysliwiec M, Bandura M, Anna Wołoszyn-Durkiewicz A, et al. 2024 Polish Recommendations for the Management of Familial Hypercholesterolemia in Children and Adolescents. Arch Med Sci 2024; 20: 1741-53.
8.
Pang J, Hu M, Lin J, et al. An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the “Ten Countries Study”. BMJ Open 2017; 7: e017817.
9.
Kwok S, Pang J, Adam S, Watts GF, Soran H. An online questionnaire survey of UK general practitioners’ knowledge and management of familial hypercholesterolaemia. BMJ Open 2016; 6: e012691.
10.
Van Den Bosch SE, Hutten BA, Ibrahim S, et al. Familial hypercholesterolemia care by Dutch pediatricians – mind the gaps. Eur J Pediatr 2024; 183: 3877-83.
11.
Vallejo-Vaz AJ, Stevens CAT, Lyons ARM, et al. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Lancet 2021; 398: 1713-25.
12.
Dharmayat KI, Vallejo-Vaz AJ, Stevens CAT, et al. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study. Lancet 2024; 403: 55-66.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
